14.10 n&v 747 MH


directly to the disease process. The debate has had especial intensity where polyglutamine diseases,and Huntington’s disease in particular, are concerned. For the polyglutamine diseases, inclusion bodies containing mutant protein sprang to public attention in a series of papers that appeared in 1997. In the case of Huntington’s disease, the critical protein… (More)


2 Figures and Tables

Cite this paper

@inproceedings{Orr20041410N7, title={14.10 n&v 747 MH}, author={Harry T. Orr}, year={2004} }